ATP citrate-lyase inhibitor SB-201076 γ-lactone prodrug with cell-permeability, oral availability and in vivo hypocholesterolaemic/hypolipidaemic efficacy.
SB-204990 is a cell-permeable and orally available γ-lactone prodrug of the non-cell-permeable SB-201076 that inhibits human and rat ATP citrate-lyase (Ki =1 μM against human and rat ACL) in a predominantly competitive manner with a small but significant uncompetitive component. SB-204990 treatment is shown to suppress the rate of cellular cholesterol and fatty acid synthesis in HepG2 cultures (by 91% & 82%, respectively, with 30 μM SB-204990), and display hypocholesterolaemic and hypolipidaemic efficacy in vivo when administered in the diet (0.05-0.25%, w/w; mice, rats, dogs).
A non-detergent sulfobetaine. Reported to prevent protein aggregation and facilitate the renaturation of chemically and thermally denatured proteins. Zwitterionic over a wide pH range. Easily removed by dialysis.
assay
≥98% (HPLC)
assay
≥97% (HPLC)
assay
≥98% (HPLC)
assay
≥99% (HPLC)
form
powder
form
solid
form
powder
form
powder
Quality Level
100
Quality Level
100
Quality Level
100
Quality Level
-
storage temp.
2-8°C
storage temp.
-
storage temp.
2-8°C
storage temp.
15-25°C
solubility
DMSO: 2 mg/mL, clear
solubility
H2O: 20 mg/mL (with heating)
solubility
DMSO: 5 mg/mL, clear (warmed)
solubility
water: 50 mg/mL
color
white to beige
color
-
color
white to beige
color
white
Storage Class
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.